Evidence map›Paper›PMID 38994379›Full record

ArticleFrontiers in transplantation2022

Role of post-transplant graft scintigraphy in kidney donation after circulatory death.

Manon Belhoste, Gilles Allenbach, Thomas Agius, Raphael P H Meier, Jean-Pierre Venetz, Jean-Marc Corpataux, Antoine Schneider, Déla Golshayan, John O Prior, Sébastien Déglise and 2 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Manon BelhosteDepartment of Vascular Surgery, Lausanne University Hospital, Lausanne, Switzerland.
Gilles AllenbachDepartment of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.
Thomas AgiusDepartment of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
Raphael P H MeierDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MD, United States.
Jean-Pierre VenetzTransplantation Center, Lausanne University Hospital, Lausanne, Switzerland.
Jean-Marc CorpatauxDepartment of Vascular Surgery, Lausanne University Hospital, Lausanne, Switzerland.
Antoine SchneiderAdult Intensive Care Unit, Lausanne University Hospital, Lausanne, Switzerland.
Déla GolshayanTransplantation Center, Lausanne University Hospital, Lausanne, Switzerland.
John O PriorDepartment of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.
Sébastien DégliseDepartment of Vascular Surgery, Lausanne University Hospital, Lausanne, Switzerland.
Marie Nicod-LalondeDepartment of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.
Alban LongchampDepartment of Vascular Surgery, Lausanne University Hospital, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is no consensus on how to predict post-transplant function of donation after circulatory death ( Methods: In this single center study, we included all consecutive DCD kidney recipients between 2013 and 2021 ( Results: Median eGFR and serum creatinine at 1 year were 67 µmol/L (56-81) and 111 ml/min (99-132), respectively. Among parameters tested, the 3rd/2nd-minute activity ratio had the best diagnostic performance (AUC: 0.74 and 0.71, for eGFR and creatinine) 1 year post transplantation. Using 1.21 as the best cut off, the 3rd/2nd-minute activity ratio specificity and sensitivity to predict eGFR >60 ml/min was 0.82 and 0.83. Renal function was significantly better at 1 week, 3, 6, and 12 months after transplantation in patients with 3rd/2nd-minute activity ratios above 1.21. Conclusion: This study suggests that the 3rd/2nd-minute activity ratio can predict graft function at 1 year. The benefit of post-transplant scintigraphy should be further validated in a prospective cohort.

Indexed as

DCD−donation after cardiac deathkidney transplantationoutcomescintigraphytranplantation

Identifiers

PMID38994379
PMCPMC11235226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.